Fluidigm INITIATED at Buy and 2 Analyst-Initiated Shares on the Move
August 31, 2012
Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on August 31st.
Fresenius Medical (NYSE:FMS): HSBC Securities initiated coverage of this company with a rating of Overweight.
Don’t Miss: Are Home Prices RECOVERING?
BG Medicine (NASDAQ:BGMD): Mizuho initiated coverage of this company with a rating of Buy and a price target of $6.
Fluidigm (NASDAQ:FLDM): Mizuho initiated coverage of this company with a rating of Buy and a price target of $17.
Don’t Miss: Here’s Why Facebook Should Follow Pandora’s Business Model.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Stories You'll Love
Wall St. Cheat Sheet has been featured in these fine media outlets:
